A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating QT/QTc Intervals Following Administration of Extended-Release Paliperidone and Quetiapine in Subjects With Schizophrenia or Schizoaffective Disorder.
Phase of Trial: Phase I
Latest Information Update: 05 May 2010
At a glance
- Drugs Paliperidone; Quetiapine
- Indications Schizoaffective disorder; Schizophrenia
- Focus Adverse reactions
- Sponsors Janssen Research & Development
- 07 Jun 2017 Biomarkers information updated
- 29 Jan 2009 Planned number of patients changed from 100 to 110 as reported by ClinicalTrials.gov.
- 28 Nov 2008 New trial record.